YS Biopharma Co, Probability of Future Stock Price Finishing Over 0.48
| YSDelisted Stock | 0.48 0.03 5.88% |
YS Biopharma |
YS Biopharma Target Price Odds to finish over 0.48
The tendency of YS Biopharma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.48 | 90 days | 0.48 | about 90.88 |
Based on a normal probability distribution, the odds of YS Biopharma to move above the current price in 90 days from now is about 90.88 (This YS Biopharma Co, probability density function shows the probability of YS Biopharma Stock to fall within a particular range of prices over 90 days) .
Allowing for the 90-day total investment horizon YS Biopharma Co, has a beta of -0.6. This entails as returns on the benchmark increase, returns on holding YS Biopharma are expected to decrease at a much lower rate. During a bear market, however, YS Biopharma Co, is likely to outperform the market. Additionally YS Biopharma Co, has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. YS Biopharma Price Density |
| Price |
Predictive Modules for YS Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as YS Biopharma Co,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of YS Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
YS Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. YS Biopharma is not an exception. The market had few large corrections towards the YS Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold YS Biopharma Co,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of YS Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.51 | |
β | Beta against Dow Jones | -0.6 | |
σ | Overall volatility | 0.18 | |
Ir | Information ratio | -0.1 |
YS Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of YS Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for YS Biopharma Co, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| YS Biopharma Co, is now traded under the symbol LSB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| YS Biopharma Co, is not yet fully synchronised with the market data | |
| YS Biopharma Co, has some characteristics of a very speculative penny stock | |
| YS Biopharma Co, has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0. | |
| YS Biopharma generates negative cash flow from operations | |
| About 81.0% of the company outstanding shares are owned by insiders |
YS Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of YS Biopharma Stock often depends not only on the future outlook of the current and potential YS Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. YS Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 93.1 M | |
| Cash And Short Term Investments | 370.1 M |
YS Biopharma Technical Analysis
YS Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. YS Biopharma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of YS Biopharma Co,. In general, you should focus on analyzing YS Biopharma Stock price patterns and their correlations with different microeconomic environments and drivers.
YS Biopharma Predictive Forecast Models
YS Biopharma's time-series forecasting models is one of many YS Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary YS Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about YS Biopharma Co,
Checking the ongoing alerts about YS Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for YS Biopharma Co, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| YS Biopharma Co, is now traded under the symbol LSB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| YS Biopharma Co, is not yet fully synchronised with the market data | |
| YS Biopharma Co, has some characteristics of a very speculative penny stock | |
| YS Biopharma Co, has a very high chance of going through financial distress in the upcoming years | |
| The company generated the yearly revenue of 687.2 M. Annual Net Loss to common stockholders was (145.48 M) with gross profit of 0. | |
| YS Biopharma generates negative cash flow from operations | |
| About 81.0% of the company outstanding shares are owned by insiders |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |